Hemenway Trust Co LLC Buys 1,271 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Hemenway Trust Co LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.4% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 53,187 shares of the healthcare conglomerate's stock after acquiring an additional 1,271 shares during the period. UnitedHealth Group makes up 2.2% of Hemenway Trust Co LLC's investment portfolio, making the stock its 21st biggest position. Hemenway Trust Co LLC's holdings in UnitedHealth Group were worth $26,905,000 as of its most recent filing with the SEC.

A number of other large investors have also added to or reduced their stakes in the company. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at about $25,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at approximately $30,000. Promus Capital LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter worth $32,000. Pillar Financial Advisors LLC purchased a new stake in UnitedHealth Group during the 4th quarter valued at $40,000. Finally, DecisionPoint Financial LLC raised its stake in shares of UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock valued at $52,000 after acquiring an additional 62 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Down 2.9 %

Shares of UNH traded down $15.50 on Friday, hitting $524.94. 9,914,705 shares of the stock traded hands, compared to its average volume of 4,256,040. The company has a market capitalization of $480.17 billion, a PE ratio of 33.87, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The business has a 50 day simple moving average of $509.24 and a 200 day simple moving average of $541.85.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company's quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the company posted $5.83 earnings per share. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. UnitedHealth Group's payout ratio is 54.19%.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm's stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.33% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research firms have commented on UNH. Truist Financial lowered their price target on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Wells Fargo & Company cut their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a report on Tuesday, January 28th. StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. KeyCorp restated an "overweight" rating and issued a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Cantor Fitzgerald reissued an "overweight" rating and issued a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of "Buy" and a consensus price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.